Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $7.5 million, versus $3.8 million reported last year.

For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.